Please assess the completion status of the following clinical trial:

Trial Title: Androgen Replacement Therapy in Women With Hypopituitarism

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria:~* Hypogonadism and/or hypoadrenalism of central origin~* Testosterone or free testosterone level below the median for age-matched normal controls~* Prior estrogen preparation for at least 6 months~Exclusion criteria:~* Any disease known to affect bone metabolism, including untreated hypothyroidism or hyperthyroidism~* Change in thyroid hormone dose in the last 3 months~* Untreated Cushing's syndrome~* Renal failure~* Alcoholism~* Anorexia nervosa~* Prior use of medication known to affect bone metabolism (e.g., supraphysiologic doses of glucocorticoids, phenytoin, bisphosphonates, or calcitonin) within the past 3 months~* Pregnant or nursing~* Uncontrolled hypertension~* ALT greater than 3 times upper limit of normal~* Serum creatinine greater than 2 times the upper limit of normal~* Any contraindication to estrogen therapy, including history of breast cancer or undiagnosed uterine bleeding~* Concurrent growth hormone replacement therapy, if patient has been receiving it for less than 2 years

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).